Edition:
United States

Dova Pharmaceuticals Inc (DOVA.OQ)

DOVA.OQ on NASDAQ Stock Exchange Global Market

25.64USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$25.64
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
53,836
52-wk High
$35.52
52-wk Low
$16.98

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Paul Manning

61 2017 Chairman of the Board

Alex Sapir

50 2017 President, Chief Executive Officer, Director

Mark Hahn

55 2018 Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer

Kevin Laliberte

39 2017 Senior Vice President - Product Development

Lee Allen

65 2017 Chief Medical Officer